dc.contributor.author | Mellick, GD | |
dc.contributor.author | Ross, OA | |
dc.date.accessioned | 2017-05-03T16:08:53Z | |
dc.date.available | 2017-05-03T16:08:53Z | |
dc.date.issued | 2011 | |
dc.date.modified | 2012-05-08T23:16:52Z | |
dc.identifier.issn | 1351-5101 | |
dc.identifier.doi | 10.1111/j.1468-1331.2011.03350.x | |
dc.identifier.uri | http://hdl.handle.net/10072/44937 | |
dc.description.publicationstatus | Yes | |
dc.language | English | |
dc.language.iso | eng | |
dc.publisher | Wiley-Blackwell Publishing Ltd. | |
dc.publisher.place | United States | |
dc.relation.ispartofstudentpublication | N | |
dc.relation.ispartofpagefrom | 671 | |
dc.relation.ispartofpageto | 672 | |
dc.relation.ispartofissue | 5 | |
dc.relation.ispartofjournal | European Journal of Neurology | |
dc.relation.ispartofvolume | 18 | |
dc.rights.retention | Y | |
dc.subject.fieldofresearch | Clinical sciences | |
dc.subject.fieldofresearch | Neurosciences | |
dc.subject.fieldofresearch | Neurology and neuromuscular diseases | |
dc.subject.fieldofresearchcode | 3202 | |
dc.subject.fieldofresearchcode | 3209 | |
dc.subject.fieldofresearchcode | 320905 | |
dc.title | Caffeine and Parkinson’s disease: are we getting our fix on risk-modifying gene-environment interactions? | |
dc.type | Journal article | |
dc.type.description | C3 - Articles (Letter/ Note) | |
dc.type.code | C - Journal Articles | |
gro.date.issued | 2011 | |
gro.hasfulltext | No Full Text | |
gro.griffith.author | Mellick, George | |